Ad
related to: most recent orphan x book order status page domain- Best Books of 2024
Amazon Editors’ Best Books of 2024.
Discover your next favorite read.
- Best Books of the Year
Amazon editors' best books so far.
Best books so far.
- Best sellers and more
Explore best sellers.
Curated picks & editorial reviews.
- Amazon Editors' Picks
Handpicked reads from Amazon Books.
Curated editors’ picks.
- Print book best sellers
Most popular books based on sales.
Updated frequently.
- Start a New Series
Best Sellers and Top Rated Series.
Find your next favorite series.
- Best Books of 2024
Search results
Results From The WOW.Com Content Network
The book centers around the character Evan Smoak. At the age of 12, he was enrolled in a top-secret operation known as the "Orphan Program." [4] He is the 24th recruit in the program and is known only as Orphan X. The goal of the program is to train orphans so they can be assassins for government agencies.
Meanwhile, in Ukraine, the lethal Candy McClure, whose code name Orphan V, remains obsessed with getting revenge on Smoak, but begins to question the methods of her organization when an innocent girl is killed by her new partner, a psychopath eunuch nicknamed Orphan M.
Gregg Andrew Hurwitz is the New York Times #1 internationally bestselling author of 24 thrillers including the Orphan X series. His novels have won numerous literary awards and have been published in 33 languages. Gregg currently serves as the Co-President of International Thriller Writers (ITW).
Note: Clearing your search history only stops your search history from being used for product features like predicting what you're searching for.
Buy a Bullet is a 2016 thriller short story written by Gregg Hurwitz.It forms a part of the "Orphan X Thrillers" series by the author. Being a short story it was published as an electronic book.
This is a list of active and upcoming DC Comics printed comic books (as opposed to digital comics, trade paperbacks, hardcover books, etc.). The list is updated as of February 23, 2025. The list is updated as of February 23, 2025.
The FDA grants Orphan Drug and Rare Pediatric Disease designations to Ultragenyx (RARE) and partner GeneTx Biotherapeutics' GTX-102 for the treatment of Angelman Syndrome.
Please help an orphan article by adding links to it in related articles and lists. Once it has an incoming link from at least one article or list the orphan tag can be removed (disambiguation pages, redirects and draft articles do not count). Three or more incoming links are ideal. The Find link tool may be of help, but not in all cases.